drugset / Trial / NCT07481708

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

NCT07481708

Phase 1 Completed 30 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.

Timeline

Start
2026-03-23
Primary completion
2026-05-18
Completion
2026-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications

No indication recorded.